Skip to main content
. 2022 Dec 5;11(12):1471. doi: 10.3390/pathogens11121471

Table 2.

Measures of success in prevention or treatment of UTI.

Measure Definition References
Number of UTI Statistically significant reduction in the number of UTIs in treatment versus placebo group. [41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,58]
Time to first UTI Statistically significant reduction in the time to first UTI in treatment versus placebo group. [33,41,44,45,46,52]
% Of patients UTI free Statistically significant difference susceptible patients who did not acquire a UTI during this study period. [33,41,42,44,45,48,49,50,51,54,55]
Duration of UTI Statistically significant difference in the total time frame patients experienced the UTI for up until symptom resolution [47]
Symptom scores Significant UTI-associated symptom relief experienced in patients after taking treatment [56,57,58,59,77]